TY - JOUR
T1 - Exploring the Potential of Nanogels
T2 - From Drug Carriers to Radiopharmaceutical Agents
AU - Kubeil, Manja
AU - Suzuki, Yota
AU - Casulli, Maria Antonietta
AU - Kamal, Rozy
AU - Hashimoto, Takeshi
AU - Bachmann, Michael
AU - Hayashita, Takashi
AU - Stephan, Holger
N1 - Funding Information:
H.S. is very grateful to the Japan Society for the Promotion of Science for financial support (Fellowship ID: S20097) under the “JSPS Invitational Fellowships for Research in Japan (Short‐term)”, which has given him the opportunity to discuss further cooperation with his Japanese colleagues. M.K., M.B., and H.S. express their gratitude for the financial support provided by the Helmholtz Initiative and Networking Fund (Radio‐Immuno‐Theranostics (MHELTHERA), project ID: InterLabs‐0031). This work was financially supported by a JSPS Grant‐in‐Aid for Scientific Research Grant Number 20H02772 (T.Hay.), 21K03452 and 23K04792 (T.Has.) and a JSPS Research Fellowship for Young Scientists PD Grant Number 21J00709 and 22KJ2748 (Y.S.). R.K. received a six‐week Trialect fellowship and gratefully acknowledged for a research training at HZDR.
Publisher Copyright:
© 2023 The Authors. Advanced Healthcare Materials published by Wiley-VCH GmbH.
PY - 2024/1/4
Y1 - 2024/1/4
N2 - Nanogels open up access to a wide range of applications and offer among others hopeful approaches for use in the field of biomedicine. This review provides a brief overview of current developments of nanogels in general, particularly in the fields of drug delivery, therapeutic applications, tissue engineering, and sensor systems. Specifically, cyclodextrin (CD)-based nanogels are important because they have exceptional complexation properties and are highly biocompatible. Nanogels as a whole and CD-based nanogels in particular can be customized in a wide range of sizes and equipped with a desired surface charge as well as containing additional molecules inside and outside, such as dyes, solubility-mediating groups or even biological vector molecules for pharmaceutical targeting. Currently, biological investigations are mainly carried out in vitro, but more and more in vivo applications are gaining importance. Modern molecular imaging methods are increasingly being used for the latter. Due to an extremely high sensitivity and the possibility of obtaining quantitative data on pharmacokinetic and pharmacodynamic properties, nuclear methods such as single photon emission computed tomography (SPECT) and positron emission tomography (PET) using radiolabeled compounds are particularly suitable here. The use of radiolabeled nanogels for imaging, but also for therapy, is being discussed.
AB - Nanogels open up access to a wide range of applications and offer among others hopeful approaches for use in the field of biomedicine. This review provides a brief overview of current developments of nanogels in general, particularly in the fields of drug delivery, therapeutic applications, tissue engineering, and sensor systems. Specifically, cyclodextrin (CD)-based nanogels are important because they have exceptional complexation properties and are highly biocompatible. Nanogels as a whole and CD-based nanogels in particular can be customized in a wide range of sizes and equipped with a desired surface charge as well as containing additional molecules inside and outside, such as dyes, solubility-mediating groups or even biological vector molecules for pharmaceutical targeting. Currently, biological investigations are mainly carried out in vitro, but more and more in vivo applications are gaining importance. Modern molecular imaging methods are increasingly being used for the latter. Due to an extremely high sensitivity and the possibility of obtaining quantitative data on pharmacokinetic and pharmacodynamic properties, nuclear methods such as single photon emission computed tomography (SPECT) and positron emission tomography (PET) using radiolabeled compounds are particularly suitable here. The use of radiolabeled nanogels for imaging, but also for therapy, is being discussed.
UR - http://www.scopus.com/inward/record.url?scp=85172283503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85172283503&partnerID=8YFLogxK
U2 - 10.1002/adhm.202301404
DO - 10.1002/adhm.202301404
M3 - Review article
C2 - 37717209
AN - SCOPUS:85172283503
SN - 2192-2640
VL - 13
JO - Advanced healthcare materials
JF - Advanced healthcare materials
IS - 1
M1 - 2301404
ER -